Is ketamine the answer to treatment-resistant depression?
While once considered a counterculture drug, ketamine is now giving hope for patients with treatment-resistant depression.
The University of Cincinnati's Stephen Rush, MD, treats patients with intranasal ketamine and esketamine in the Treatment Resistant Depression Clinic and joined WVXU's Cincinnati Edition to discuss the drugs' benefits and the importance of administering the drug in a safe and controlled setting.
Rush explained ketamine was initially developed as an anesthetic, and its "mirror image" molecule esketamine has been approved by the FDA for treatment-resistant depression.
"Ketamine or esketamine impact an entirely different molecule in the brain (than traditional antidepressants)," said Rush, associate professor of clinical psychiatry in UC's College of Medicine and medical director of ambulatory services. "Ketamine increases the neuroplasticity of the brain. That is, it increases the ability of our nervous system to change its activity by reorganizing its structure, functions and connections with other parts of the brain, going from a function causing depression to a function in which depression is no longer present."
Rush said administering intranasal ketamine and esketamine in the clinic is structured with safety in mind, as vital signs like heart rate and blood pressure are monitored, side effects are reported and patients stay for 2-4 hours after treatment to confirm their vital signs are in normal range and they are safe to be discharged.
"My personal opinion is that the data on safety around home-use ketamine is not there yet, and I would generally advise against it," Rush said. "Certainly someone who is participating in treatment in our clinics cannot also be getting home treatment through another service."
Since the use of ketamine or esketamine is focused on people who have failed traditional treatments, Rush said it is exciting to see patients entering remission from depression through this treatment. Meta-analyses of studies have found likelihood of remission with esketamine treatment is about 30-45%, while likelihood of having at least a 50% reduction in symptoms is about 40-55%.
"I often hear about patients telling me about how life has changed, whether that means going back to work and coming off of disability, or going back to school, engaging in relationships in ways they haven’t for years and generally functioning," Rush said. "Not only are we talking about the improvement in mood, we’re talking about the increase in functioning and the person’s ability to contribute to society and be productive, which is a huge factor in determining someone's sense of wellness."
Listen to the Cincinnati Edition segment.
Featured photo at top of ketamine vial. Photo/Jennifer Fontan/iStock.
Latest UC News
- UC Law hosted forum discussing election security, American democracy and civilityThe American Bar Association Task Force for American Democracy brought a host of speakers to the University of Cincinnati College of Law as part of a country-wide listening tour. Former Homeland Security Security Jeh Johnson was the event's keynote speaker. He highlighted the importance of election security and the need to protect American democracy.
- From scholarships to scalpelsIn her fourth year at the University of Cincinnati College of Medicine, Kamala Nelson is on the brink of realizing her dream of becoming a surgeon. But her path to this point has been anything but ordinary. It’s been a journey marked by rigorous academic challenges, a passion for helping underserved communities and — perhaps most crucially — the financial support of scholarships that made it all possible.
- UC grad fights for housing equality in CincinnatiLaTonya Springs has been around Cincinnati for a long time. A 2015 University of Cincinnati graduate, Springs has spent her time in and around Cincinnati, connecting with the people and learning about their lives and struggles, all with the hope of helping them fight for better conditions in the area. After starting her education, she was working full-time, which left her in a situation where finishing college didn’t make a lot of sense. However, once UC started a new program called Comeback Bearcat, Springs was able to come back and finish her undergraduate degree in communication, offered through the College of Arts and Sciences.
- Nominations open for All-University Faculty AwardsThe final nomination deadline for this year’s All-University Faculty Awards is Wednesday, November 20, 2024. In all, 12 different awards are offered through our 2024-25 All-University Faculty Awards competition.
- The multiple ways climate change threatens to make migraines worseThe University of Cincinnati's Vince Martin, MD, was featured in a Wired article discussing how climate change could worsen migraines.
- UC celebrates National Postdoc Appreciation WeekThe University of Cincinnati has a long list of events lined up to honor its postdoctoral fellows as colleges across the country celebrate National Postdoc Appreciation Week.